Clinical Trial
-
Trial to test aortic valve technique in lower-risk patients
In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States. Read MoreOct 27, 2016
-
VICC trial putting lung cancer therapy to the test
Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis. Read MoreOct 20, 2016
-
First subject enrolled in international HIV prevention study
This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1. Read MoreApr 14, 2016
-
VUMC study finds statins do not ease kidney injury following cardiac surgery
Among doctors, it is widely believed that a class of drugs called statins, which are used to lower cholesterol, might help patients tolerate the stress of cardiac surgery. Not so, according to a five-year, placebo-controlled, double-blinded randomized clinical trial conducted at Vanderbilt University Medical Center, published today in the… Read MoreFeb 23, 2016
-
Diabetes trial targets body’s ability to produce insulin
Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment. Read MoreSep 10, 2015
-
ResearchMatch adds new clinical trials feature
Patients seeking to participate in clinical trials have a new option in online tools for finding studies that might offer hope for their problem or condition. Read MoreMar 26, 2015
-
Vanderbilt to study use of plasma on LifeFlight, extends trial to Rutherford County base
Vanderbilt University Medical Center is participating in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Randomized patients who are at risk of hemorrhaging could receive… Read MoreFeb 25, 2015
-
VU study explores optimal timing for pertussis vaccine
Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection. Read MoreFeb 12, 2015
-
Research Subjects’ Bill of Rights available online
As the number of opportunities to participate in research studies continues to grow, the Vanderbilt Human Research Protection Program (HRPP) would like study participants to be aware of the Research Subjects’ Bill of Rights. Read MoreOct 13, 2014
-
DBS for Parkinson’s trial moves to next level
A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial. Read MoreApr 3, 2014
-
Heart Institute studying absorbable coronary stent
Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease. Read MoreNov 14, 2013
-
Vanderbilt to study use of plasma on LifeFlight
Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Read MoreOct 29, 2013
-
Glucose control study gives patients new path to health
The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating. Read MoreOct 24, 2013
-
VU tracking drug’s ability to prevent type 1 diabetes
Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read MoreSep 12, 2013
-
Defining patient retention
Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations. Read MoreJul 15, 2013
-
Continuity of care initiative focuses on patients exiting clinical trials
The Vanderbilt Breast Center is piloting new measures to ensure continuity of care and timely insurance preauthorization as patients come off grant-sponsored clinical trial protocols and begin or resume standard care. Read MoreMay 30, 2013
-
ResearchMatch adds registry for autism disorders
ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies. Read MoreJan 31, 2013
-
Better blood pressure-reducing drugs?
A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome. Read MoreApr 30, 2012
-
Matchmaker for clinical studies
ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies. Read MoreFeb 8, 2012
-
VUCast: Laughing Gas For Labor
This week on VUCast, Vanderbilt’s weekly newscast highlighting research, experts, students, sports and everything Vanderbilt: Laughing gas for labor Searching for alien planets What Vanderbilt WON at the Liberty Bowl [vucastblurb]… Read MoreJan 11, 2012